Insider Trading April 6, 2026

Culp Inc CCO Acquires 10,000 Shares as Company Grapples with Weak Quarterly Results

Bruno Thomas increases stake amid a stock trading near its 52-week low and a fiscal quarter that missed expectations

By Leila Farooq CULP
Culp Inc CCO Acquires 10,000 Shares as Company Grapples with Weak Quarterly Results
CULP

Chief Commercial Officer Bruno Thomas purchased 10,000 shares of Culp Inc common stock on April 2, 2026, spending $27,650 on shares priced between $2.75 and $2.78. The transaction leaves Thomas with 90,000 shares directly held. The trade comes as the stock changes hands at $2.71, roughly 1% above its 52-week low of $2.70, and after the company reported a disappointing third-quarter fiscal 2026 that missed both earnings-per-share and revenue estimates.

Key Points

  • Culp Inc CCO Bruno Thomas bought 10,000 shares on April 2, 2026 at $2.75 to $2.78, totaling $27,650 and bringing his direct holdings to 90,000 shares.
  • The stock traded at $2.71, about 1% above its 52-week low of $2.70, while InvestingPro analysis flagged the share price as undervalued relative to Fair Value.
  • Culp missed fiscal third-quarter 2026 expectations, reporting EPS of -$0.27 versus an expected -$0.07 and revenue of $47.97 million versus a $54.00 million projection - developments that continue to weigh on investor sentiment and U.S. equity trading in the company.

Chief Commercial Officer Bruno Thomas reported a purchase of 10,000 shares of Culp Inc common stock on April 2, 2026. The trades were executed at prices ranging from $2.75 to $2.78, bringing the total outlay to $27,650. Following the transaction, Thomas directly holds 90,000 shares of the company.

The timing of the insider buy stands out given the stock's recent trading level. Culp's shares were trading at $2.71 at the time of the report, approximately 1% above the 52-week low of $2.70. An InvestingPro analysis cited in the report indicates the stock appears undervalued relative to its Fair Value, placing Culp among equities flagged as potential opportunities on a list of most undervalued stocks.

Investors seeking more detailed valuation and financial analysis can consult the Pro Research Report, which is available for CULP along with more than 1,400 other U.S. equities.

The insider purchase follows a difficult quarterly report. Culp Inc disclosed third-quarter fiscal 2026 results that fell short of expectations on both the earnings-per-share and revenue fronts. The company posted EPS of -$0.27, missing the consensus estimate of -$0.07. Revenue for the quarter came in at $47.97 million versus the $54.00 million projection.

Those results underscore the ongoing financial challenges the company is facing. The earnings announcement also prompted a pre-market decline in the stock price, a market reaction noted in the report though price moves were not the principal focus of the disclosure.

Market participants and analysts are watching these developments closely as the company's recent performance remains a point of concern. The insider transaction by the chief commercial officer and the InvestingPro valuation note add context to the current investor debate over valuation and company fundamentals.


Further details:

  • Transaction date: April 2, 2026.
  • Shares purchased: 10,000.
  • Purchase price range: $2.75 - $2.78.
  • Total amount spent: $27,650.
  • Direct ownership after trade: 90,000 shares.
  • Reported quarterly EPS: -$0.27 versus expected -$0.07.
  • Reported quarterly revenue: $47.97 million versus projected $54.00 million.

Risks

  • Continued weakness in company financials - the reported EPS and revenue both missed expectations, signaling ongoing operational or demand challenges that could further pressure the stock and investor sentiment.
  • Share price volatility - the stock is trading near its 52-week low and experienced a pre-market decline after the earnings release, indicating potential for further short-term fluctuations in the U.S. equities market.
  • Uncertainty around valuation - while InvestingPro flagged Culp as potentially undervalued relative to Fair Value, that assessment contrasts with the recent earnings miss and introduces uncertainty for investors assessing risk-reward profiles.

More from Insider Trading

Japan Post Holdings Disposes of 20,100 Aflac Shares in $2.2M Sale Apr 6, 2026 Insider Increase: Jorey Chernett Buys $253,800 of AirSculpt Technologies Stock Apr 6, 2026 Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026